Publicação científica trimestral do CREMERJ - número 2 - 2022

81 Med. Ciên. e Arte , Rio de Janeiro, v.1, n.2, p.75-82, abr-jun 2022 Suporte avançado de oxigenoterapia e medidas de resgate em ventilação mecânica invasiva na COVID-19 Luciana Tagliari e Saulo Beiler REFERÊNCIAS 1. Liaqat A et al. Evidence-based mechanical ventilatory strategies in ARDS. J Clin Med 2022, 11,319. doi: 10.3390/jcm11020319 2. Ospina-Tascón GA et al. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19. JAMA. 2021; 326(21):2161-2171. DOI: 10.1001/jama.2021.20714 3. Mellado-Artigas R et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Critical Care 2021, 25:58. doi: 10.1186/s13054-021-03469-w. 4. Xu Q et al. Early awake prone position combined with High-flow nasal oxygen therapy in severe COVID-19: a case series. Critical Care 2020, 24:250. doi: 10.1186/s13054-020-02991-7. 5. Esperatti M et al. Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study. Critical Care 2022, 26:16. doi: 10,1186/s13054-021-03881-2. 6. Tu G-W et al. Prone positioning in high-flow nasal cannula for COVID-19 patients with severe hypoxemia: a pilot study. Ann Transl Med 2020; 8(9):598. doi: 10.21037/atm-20-3005. 7. Garner O et al. Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19. Respiratory Medicine 185(2021)106474. doi: 10.1016/j.rmed.2021.106474. 8. Baek AR et al. Late failure of high flow nasal cannula may be associated with high mortality in COVID-19 patients: A multicenter retrospective study in the repuplic of Korea. J Pers Med. 2021, 11, 989. doi: 10.3390/ jpm11100989 9. Cabrini L et al. A noninvasive ventilation and survival in acute care settings: A comprehensive systematic review and metaanalysis of randomized controlled trials. Crit Care. 2015, 43, 880-888. doi: 10.1097/ CCM.0000000000000819 10. Schnell D et al. Noninvasive mechanical ventilation in acute respiratory failure: Trends in use and outcomes. Intensive Care Med. 2014, 40, 582-591. doi: 10.1007/s00134-014-3222-y. 11. Cummings MJ et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395:1763–70. doi: 10.1016/S0140-6736(20)31189-2. 12. Coppadoro A et al. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care. 2021;25:80. DOI: 10.1186/s13054-021-03502-y 13. Grieco DL et al. Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial. JAMA 2021, 325, 1731–1743 doi: 10.1001/jama.2021.4682. 14. Ing RJ et al. Role of helmet delivered noninvasive pressure support ventilation in COVID-19 patients. J Cardiothorac Vasc Anesth. 2020;34:2575-9. doi: 10.1053/j.jvca.2020.04.060. 15. Sullivan ZP et al. Noninvasive respiratory support for COVID-19 patients: When, for whom, and how? Journal of Intensive Care 2022, 10:3. doi: 10.1186/s40560-021-00593-1. 16. Liu L et al. A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study. Lancet Digit Health. 2021;3:e166-74. doi:10.1016/S2589- 7500(20)30316-2. 17. Carteaux G et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med. 2016;44:282–90. doi: 10.1097/CCM.00000000000001379. 18. Fan E et al. COVID-19 associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med 2020;8:816-21. doi: 10.1016/S2213-2600(20)30304-0. 19. Gattinoni L et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020 46;46(6):1099-1102 doi: 10.1007/s00134-020-06033-2.

RkJQdWJsaXNoZXIy ODA0MDU2